GURU.Markets stock price, segment price, and overall market index valuation
The company's share price LivaNova PLC
LivaNova is a medical equipment company specializing in cardiac surgery and neuromodulation devices. Its stock price is driven by the volume of surgical procedures and innovations in the treatment of epilepsy and depression.
Share prices of companies in the market segment - Miscellaneous medical equipment
LivaNova is a manufacturer of medical equipment for cardiac surgery and neuromodulation. We classify it as part of the diversified medical equipment sector, and the chart below illustrates the overall dynamics of this innovation-driven market.
Broad Market Index - GURU.Markets
LivaNova is a global medical device company that develops and manufactures innovative equipment for the treatment of cardiovascular diseases and neuromodulation. Its significant market capitalization earns it a prominent place in the GURU.Markets index. The chart below represents the entire market. Find out how LivaNova compares to it.
Change in the price of a company, segment, and market as a whole per day
LIVN - Daily change in the company's share price LivaNova PLC
The daily price change of LivaNova, a manufacturer of medical equipment for cardiac surgery and neurology, is a measure of its sensitivity to medical innovation. Change_co reflects volatility associated with sales and the development of new devices. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Miscellaneous medical equipment
LivaNova PLC is a diversified medical device company. This chart shows average daily volatility. Comparison with LIVN, with its focus on cardiac surgery and neuromodulation, helps assess its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
LivaNova is a global healthcare company specializing in devices for the treatment of cardiovascular and neurological diseases. The chart below shows overall volatility in the healthcare sector, allowing one to assess how LivaNova fits in with overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization LivaNova PLC
LivaNova is a diversified medical equipment manufacturer. Its annual performance provides a broad snapshot of key healthcare sectors. The chart shows how its strategy for operating in niche markets creates stable shareholder value.
Annual dynamics of market capitalization of the market segment - Miscellaneous medical equipment
LivaNova PLC is a global healthcare company specializing in technologies for the treatment of cardiovascular and neurological diseases. The chart shows how its innovative products, such as neuromodulation systems, and competition in the medical device sector impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
LivaNova, a manufacturer of medical devices for the treatment of the heart and nervous system, operates in the defense sector. Demand for its products is driven by medical needs, not the state of the economy. The company's share price reflects its success in innovation and sales, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization LivaNova PLC
LivaNova, a medical device company specializing in devices for the treatment of cardiovascular and neurological diseases, displays monthly fluctuations reflecting clinical trial data and the commercial success of its innovative therapeutic systems.
Monthly dynamics of market capitalization of the market segment - Miscellaneous medical equipment
LivaNova PLC is a global medical device company specializing in cardiovascular treatment and neuromodulation. Its sector dynamics, shown in the graph, reflect medical innovation. This allows us to assess how its leading cardiac surgery and epilepsy treatment products position the company in the high-tech medical market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
LivaNova is a company that produces medical equipment for cardiac surgery and neuromodulation. Demand for its products is unaffected by economic cycles. The chart below shows how the defensive nature of its life-saving business has made LivaNova's shares more resilient to market downturns.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization LivaNova PLC
Shares of LivaNova, a manufacturer of medical equipment for cardiac surgery and neuromodulation, react to medical news. Weekly performance depends on clinical trial results, regulatory approvals, and sales reports. The chart below illustrates how short-term events in high-tech medicine affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Miscellaneous medical equipment
How does LivaNova's performance compare to the overall medical equipment market? This chart compares the company's weekly stock price movements with the sector average. This helps us understand whether the company is outperforming its competitors thanks to its innovations in cardiac surgery and neuromodulation, or whether its stock is moving in line with industry-wide news and regulatory changes.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
LivaNova produces medical equipment for the treatment of cardiovascular and neurological diseases. This chart compares its weekly performance to the market. It helps us understand whether its shares are behaving like a stable medical company, less susceptible to economic cycles, or whether product news is causing volatility.
Market capitalization of the company, segment and market as a whole
LIVN - Market capitalization of the company LivaNova PLC
LivaNova PLC's market valuation shows how investors view its innovative medical technologies for treating the heart and nervous system. The company's market capitalization depends on the successful implementation of its devices, such as vagus nerve stimulators. The chart illustrates the risks and hopes associated with developing cutting-edge medical technology solutions.
LIVN - Share of the company's market capitalization LivaNova PLC within the market segment - Miscellaneous medical equipment
LivaNova is a global company developing medical technologies for the treatment of cardiac and nervous system diseases. Its share of the medical devices sector's market capitalization reflects the value of its innovative products, such as neuromodulation systems. The chart shows how the market values โโits development portfolio and its ability to improve the lives of patients worldwide.
Market capitalization of the market segment - Miscellaneous medical equipment
The chart illustrates the total value of manufacturers of complex medical equipment. LivaNova, with a focus on cardiac surgery and neuromodulation, is a key innovator. The dynamics in the diagram show how the market values โโtechnologies that treat the most complex heart and brain diseases.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart reflects the economic weight of innovations that save lives in heart surgery. The market capitalization of LivaNova, a manufacturer of heart-lung machines and neurostimulators, is the market valuation of its advanced medical technologies. Its share of the economy is the cost of treating critical illnesses.
Book value capitalization of the company, segment and market as a whole
LIVN - Book value capitalization of the company LivaNova PLC
This is an assessment of the assets of LivaNova, a manufacturer of innovative medical equipment. The chart reflects the value of its factories, research centers, and patents for cardiac surgery and neuromodulation devices. The growth of this line reflects investments in technologies that are changing approaches to treating complex diseases.
LIVN - Share of the company's book capitalization LivaNova PLC within the market segment - Miscellaneous medical equipment
LivaNova's physical infrastructure consists of factories and laboratories where high-tech medical devices for cardiac surgery and neuromodulation are developed and manufactured. The chart shows the company's share of the sector's production capacity, reflecting its contribution to creating the material base for saving lives.
Market segment balance sheet capitalization - Miscellaneous medical equipment
LivaNova is a company that manufactures complex medical devices for the heart and brain. It owns high-tech factories where they create pacemakers and neuromodulation systems. This is a capital-intensive business. The chart illustrates how dependent the entire medical technology industry is on investment in advanced manufacturing facilities.
Book value of all companies included in the broad market index - GURU.Markets
LivaNova's balance sheet consists of factories and intellectual property that create high-tech medical equipment for the treatment of the heart and nervous system. The company's assets represent capital invested in saving lives. The chart shows its production and scientific weight in the global medical equipment industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - LivaNova PLC
LivaNova produces complex medical devices, such as those for cardiac surgery and neuromodulation. Its balance sheet reflects its factories and equipment, but its true value lies in its patents, clinical data, and regulatory approvals. The chart shows the premium the market places on innovation and the technological barriers to entry for competitors.
Market to book capitalization ratio in a market segment - Miscellaneous medical equipment
LivaNova produces medical equipment for cardiac surgery and neuromodulation. The company combines manufacturing capabilities with innovative, patented technologies. The chart shows how investors value this balance. The high premium to book value indicates the value of its intellectual property.
Market to book capitalization ratio for the market as a whole
LivaNova is a global company producing medical technologies for cardiac surgery and neuromodulation. This chart shows how the market values โโits portfolio of high-tech and often patented devices. The premium between market value and book value reflects the value of its intellectual property, its reputation with physicians, and the potential for new products in development.
Debts of the company, segment and market as a whole
LIVN - Company debts LivaNova PLC
LivaNova develops and manufactures innovative medical equipment for the treatment of cardiovascular and neurological diseases. Debt can be used to finance expensive research, clinical trials, and the commercialization of new technologies. This chart shows how the company manages its finances on its path to medical breakthroughs.
Market segment debts - Miscellaneous medical equipment
LivaNova is a global company producing medical equipment for cardiac surgery and neuromodulation. The medical equipment sector requires significant and ongoing investment in research, development, and clinical trials. This chart illustrates industry financial standards, which can be used to analyze how LivaNova funds its life-saving innovations.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio LivaNova PLC
LivaNova is a global company developing medical technologies for the treatment of cardiac and nervous system diseases. Competition in this field requires constant and significant investment in research and development. This chart illustrates how LivaNova finances its innovations, balancing equity and debt.
Market segment debt to market segment book capitalization - Miscellaneous medical equipment
LivaNova develops and manufactures innovative medical equipment for the treatment of cardiovascular and neurological diseases. This chart compares the company's debt, required to finance R&D and production, to the overall market capitalization of the entire medical equipment sector. It helps assess the extent of its investment in advanced technologies.
Debt to book value of all companies in the market
LivaNova develops vital medical equipment. This chart compares the company's debt to the overall book value of the economy. It helps assess how the company finances its expensive research and production in the context of the overall market conditions, which are the source of its capital.
P/E of the company, segment and market as a whole
P/E - LivaNova PLC
This metric for LivaNova PLC, a manufacturer of medical equipment for cardiac surgery and neuromodulation, demonstrates its market valuation. In the high-tech medical sector, it reflects how investors view its innovative products and their market potential. Movements in this metric may indicate expectations for approval of new devices.
P/E of the market segment - Miscellaneous medical equipment
This chart shows the average valuation for the medical device manufacturing sector in which LivaNova operates. In this stable and innovative industry, this metric serves as a benchmark reflecting overall growth expectations. Comparisons with this metric help understand whether investors perceive LivaNova to stand out from its peers and why.
P/E of the market as a whole
LivaNova is a global company developing medical technologies for the treatment of cardiac and nervous system diseases. Its devices, such as heart valves and neurostimulators, save and improve lives. This chart shows how the market as a whole views innovation in the medical device sector and assesses its potential.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company LivaNova PLC
LivaNova is a global company developing medical technologies for the treatment of cardiac and nervous system diseases. This chart reflects analyst expectations for future sales of its innovative devices, such as vagus nerve stimulators. It represents the market's assessment of the company's ability to bring new technologies to market and compete in the medical device sector.
Future (projected) P/E of the market segment - Miscellaneous medical equipment
LivaNova is a global medical technology company. It develops and manufactures equipment and treatment methods for cardiac surgery (heart-lung machines) and neuromodulation (epilepsy treatment). This chart shows average expectations for the medical device sector, helping to evaluate LivaNova in the context of healthcare innovation.
Future (projected) P/E of the market as a whole
LivaNova PLC is a global medical device company specializing in cardiovascular and neuromodulation devices. Demand for its products is driven by medical needs and an aging population, providing stability amidst general market cycles.
Profit of the company, segment and market as a whole
Company profit LivaNova PLC
LivaNova is a global company developing and manufacturing medical technologies for the treatment of cardiovascular diseases and neuromodulation. Its profits depend on sales of innovative equipment, such as heart-lung machines and vagus nerve stimulators. This chart shows how the implementation of new technologies in hospitals impacts cash flow.
Profit of companies in the market segment - Miscellaneous medical equipment
LivaNova PLC is a global medical technology company producing devices for the treatment of cardiovascular diseases and neuromodulation. This chart shows the overall profitability of the medical device sector. Demand for LivaNova's products is driven by an aging population and chronic diseases. Its innovation and market share directly impact the overall profitability dynamics in this niche.
Overall market profit
LivaNova is a global company developing medical technologies for the treatment of cardiovascular and neurological diseases. Demand for its products (such as pacemakers) is driven by medical needs, not the state of the economy. This chart illustrates common economic cycles, against which the healthcare sector often demonstrates its defensive nature.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company LivaNova PLC
LivaNova is a global company developing medical technologies for the treatment of cardiac and neurological disorders. This chart reflects analysts' forecasts for future revenue, which depend on the successful implementation of its innovative devices and procedures. It also shows market expectations regarding demand for advanced medical solutions in cardiology and neuromodulation.
Future (predicted) profit of companies in the market segment - Miscellaneous medical equipment
LivaNova PLC is a global medical technology company developing devices for the treatment of cardiovascular diseases and neuromodulation. This chart shows profitability forecasts for the medical device sector. It reflects expectations for the adoption of new technologies in medicine and the volume of surgical procedures, which impacts demand for LivaNova's products.
Future (predicted) profit of the market as a whole
LivaNova is a global company creating medical technologies for the treatment of cardiac and nervous system diseases. The development and implementation of such equipment requires significant investment from healthcare systems. The positive corporate profit forecast reflected here indirectly impacts hospital budgets, allowing them to purchase LivaNova's cutting-edge life-saving devices.
P/S of the company, segment and market as a whole
P/S - LivaNova PLC
LivaNova is a global company developing medical technologies for the treatment of cardiac and nervous system diseases. The P/S ratio for such a company reflects how the market values โโits portfolio of innovative products and their growth potential. This chart shows how much investors are willing to pay for each dollar of sales, believing in the future of its life-saving technologies.
P/S market segment - Miscellaneous medical equipment
LivaNova is a global company developing medical technologies for the treatment of cardiovascular and neurological diseases. Their revenue depends on innovation and the clinical adoption of their devices. This chart shows the market premium they command for their product portfolio and research compared to other medical device manufacturers.
P/S of the market as a whole
LivaNova is a company that produces medical equipment for the treatment of cardiovascular and neurological diseases. Revenue depends on innovation, regulatory approval, and acceptance by the medical community. This chart shows the overall revenue estimate and provides context for understanding the market premium for technology and growth potential in the medical equipment sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company LivaNova PLC
LivaNova is a global company producing medical technologies for the treatment of cardiovascular diseases and neuromodulation. Its growth depends on innovation and the adoption of its devices in clinics. This figure illustrates market expectations for future sales, taking into account demographic trends and the need for advanced treatment methods.
Future (projected) P/S of the market segment - Miscellaneous medical equipment
LivaNova PLC is a global medical technology company developing devices for the treatment of cardiovascular diseases and neuromodulation. This chart shows how the market values โโthe future sales of its innovative products compared to its competitors in the medical device sector. It reflects investor confidence in its technological leadership and commercial potential.
Future (projected) P/S of the market as a whole
LivaNova develops and manufactures innovative medical equipment for cardiac surgery and neuromodulation. The company operates at the intersection of technology and medicine, offering solutions for complex conditions. This chart shows aggregate market expectations for future revenue, and LivaNova illustrates how investments in advanced medical technologies shape long-term growth expectations.
Sales of the company, segment and market as a whole
Company sales LivaNova PLC
LivaNova PLC is a global medical technology company specializing in cardiovascular and neuromodulation devices. The chart shows revenue from products such as heart-lung machines and vagus nerve stimulators. Growth is driven by innovation and hospital demand for its equipment.
Sales of companies in the market segment - Miscellaneous medical equipment
LivaNova is a global company specializing in medical technologies for the treatment of the heart and nervous system. This chart breaks down revenue by key product segments, such as heart-lung machines and neuromodulation devices. This allows investors to assess which area is driving the company's primary growth.
Overall market sales
LivaNova is a global company developing medical technologies to treat diseases of the heart and nervous system. Demand for its life-saving devices, such as pacemakers, is relatively unaffected by economic cycles. This chart only provides a general overview, while LivaNova's revenue is driven by innovation, demographics, and healthcare budgets.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company LivaNova PLC
LivaNova develops and manufactures medical devices for the treatment of cardiovascular and neurological diseases. Its revenue forecast depends on the volume of surgical procedures and the implementation of its technologies in hospitals. This chart shows how analysts estimate the demand for innovative medical equipment within the healthcare system.
Future (projected) sales of companies in the market segment - Miscellaneous medical equipment
LivaNova is a global company developing medical technologies for the treatment of cardiovascular and neurological diseases. This chart shows projected revenues for the entire medical device sector. It helps understand the expected growth in healthcare investment, which directly impacts demand for LivaNova's innovative devices and therapeutic systems.
Future (projected) sales of the market as a whole
LivaNova develops and manufactures medical devices for the treatment of cardiovascular and neurological diseases. Demand for its products depends on healthcare system budgets and elective surgeries. This general economic forecast schedule influences government healthcare spending. Economic growth allows hospitals to invest more in LivaNova's cutting-edge technologies.
Marginality of the company, segment and market as a whole
Company marginality LivaNova PLC
LivaNova is a global company producing medical equipment for the treatment of cardiovascular and neurological diseases. This chart shows how innovation in medtech translates into financial results. Profitability depends on the ability to develop and market high-tech, patent-protected products worldwide.
Market segment marginality - Miscellaneous medical equipment
LivaNova is a global medical technology company specializing in cardiovascular and neuromodulation devices. This metric reflects the value of its innovative products. Above-industry profitability reflects a strong market position, protected by patents, and high demand from physicians.
Market marginality as a whole
LivaNova PLC is a global company developing medical technologies for the treatment of cardiac and nervous system diseases. Its success depends on innovation and market penetration with new devices. This chart shows average profitability for the market, while LivaNova can achieve higher margins thanks to protected patents and unique technologies.
Employees in the company, segment and market as a whole
Number of employees in the company LivaNova PLC
LivaNova is a global company developing and manufacturing medical technologies for cardiac surgery and neuromodulation. Its growing staff, including engineers, scientists, and sales specialists, reflects its investment in R&D and efforts to commercialize innovative products, such as heart-lung machines.
Share of the company's employees LivaNova PLC within the market segment - Miscellaneous medical equipment
LivaNova is a global medical technology company specializing in devices for the treatment of cardiovascular and neurological diseases. This chart illustrates its scientific and manufacturing scale. It reflects the proportion of medical engineers, clinicians, and manufacturing personnel LivaNova brings together in their narrow but vital niches.
Number of employees in the market segment - Miscellaneous medical equipment
LivaNova PLC is a global company creating medical technologies for the treatment of cardiac and nervous system diseases. This chart illustrates employment in the medical device sector. The growing number of specialists in this field reflects LivaNova's ongoing commitment to innovation and increased investment in the development of new therapeutic devices, which is the core of its business.
Number of employees in the market as a whole
LivaNova develops and manufactures cutting-edge medical equipment for cardiac surgery and neuromodulation. The growth of its engineers and clinical specialists reflects medical innovation and the demand for high-tech solutions. This is an example of how knowledge-intensive industries contribute to overall employment by creating high-quality jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company LivaNova PLC (LIVN)
LivaNova is a global company producing medical equipment for cardiac surgery and neuromodulation. Their value lies in sophisticated technologies, patents, and reputation in the medical community. This chart shows that each company employee is backed by significant intellectual capital and sophisticated production assets, which contributes to their high valuation.
Market capitalization per employee (in thousands of dollars) in the market segment - Miscellaneous medical equipment
LivaNova is a high-tech medical company specializing in complex devices such as neuromodulators (for epilepsy treatment) and heart-lung machines. The company's value lies in its R&D and patents. This chart shows the industry average. It helps assess the market premium for this complex expertise per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
LivaNova is a global company developing medical technologies for the treatment of cardiac and nervous system diseases, such as pacemakers. Creating such complex devices requires an elite team of engineers and scientists. This graph reflects the market premium placed on intellectual capital capable of creating innovative, life-saving products.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company LivaNova PLC (LIVN)
LivaNova is a company developing medical devices for the treatment of cardiovascular diseases and neuromodulation (for example, for epilepsy). It's a high-tech business that requires extensive R&D and clinical trials. This chart shows how successfully the company sells its innovative, but expensive, devices, generating profit per employee.
Profit per employee (in thousands of dollars) in the market segment - Miscellaneous medical equipment
LivaNova is a medical technology company focused on complex technologies (neuromodulation, cardiac surgery). This chart shows the benchmark for "Medical Equipment." This sector has high employee profitability. The benchmark is determined by patents: profit is generated through the sale of high-margin innovative implants and devices.
Profit per employee (in thousands of dollars) for the market as a whole
LivaNova is a global MedTech company specializing in cardiac surgery (heart-lung machines) and neuromodulation (epilepsy treatment). This high-tech medical equipment is a key component of the company's operations. This indicator, which shows the average contribution of one employee to profit, allows us to assess how profitable this sector is per specialist.
Sales to employees of the company, segment and market as a whole
Sales per company employee LivaNova PLC (LIVN)
LivaNova, a manufacturer of medical equipment for cardiac surgery and neuromodulation, demonstrates the value of its innovations in this chart. High revenue per employee reflects the cost and complexity of the devices it produces. This growth demonstrates its strong market position and the demand for its technologies in clinics worldwide.
Sales per employee in the market segment - Miscellaneous medical equipment
LivaNova is a global medical equipment company, particularly for neuromodulation and cardiac surgery. In high-tech medical technology, R&D and sales productivity are crucial. This chart shows the average revenue per employee in this segment. It allows us to assess how effectively LivaNova competes with other medical equipment manufacturers.
Sales per employee for the market as a whole
LivaNova is a company that produces medical equipment for cardiac surgery and neuromodulation. It's a high-tech business that requires significant investment in R&D. This indicator demonstrates the demand for their complex and expensive devices. The rising graph indicates that their innovations are being successfully commercialized and their production lines are operating efficiently.
Short shares by company, segment and market as a whole
Shares shorted by company LivaNova PLC (LIVN)
LivaNova is a medical equipment company specializing in two areas: cardiac surgery (heart-lung machines) and neuromodulation (epilepsy treatment). This chart highlights concerns about their prospects. "Bears" may be concerned about competition or the slow adoption of their technologies in hospitals.
Shares shorted by market segment - Miscellaneous medical equipment
LivaNova is a company that produces medical equipment for the treatment of cardiovascular and neurological diseases (e.g., pacemakers). This chart shows the overall sentiment in the medical equipment sector. An increase in short positions in the sector may signal that investors are concerned about delays in the approval of new devices or hospital budget cuts for high-tech equipment.
Shares shorted by the overall market
LivaNova (LIVN) is a medical equipment company specializing in cardiac surgery and neuromodulation devices (for epilepsy treatment). This is the high-tech sector in medicine. This chart illustrates the overall market fear. Even the "defensive" medical equipment sector suffers when market panic increases, as investors may fear hospitals cutting their budgets for expensive equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator LivaNova PLC (LIVN)
LivaNova produces medical devices for cardiac surgery and neuromodulation. Its business depends on the volume of elective surgeries. This chart for LIVN above 70 may reflect strong demand for procedures. A level below 30 may be related to concerns about pressure on hospital budgets or product shortages.
RSI 14 Market Segment - Miscellaneous medical equipment
LivaNova is a global medical device company specializing in two areas: cardiovascular surgery (heart-lung machines) and neuromodulation (epilepsy treatment). This chart reflects the overall health of the medical device sector and helps assess whether the sector is oversold.
RSI 14 for the overall market
LivaNova (LIVN) produces medical devices (for example, for cardiac surgery). This chart reflects hospital readiness for elective surgeries. During periods of euphoria and stability in the healthcare system, hospitals actively perform expensive procedures. During periods of panic and crisis (such as the pandemic), elective surgeries are postponed, which impacts demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast LIVN (LivaNova PLC)
LivaNova PLC is a medical device company focused on cardiovascular treatment and neuromodulation (e.g., epilepsy). This chart shows the average analyst forecast. Their target prices are based on sales forecasts for key devices, approvals for new technologies, and the competitive environment in the medical technology market.
The difference between the consensus estimate and the actual stock price LIVN (LivaNova PLC)
LivaNova is a medical device company focused on two distinct areas. The first is cardiac surgery (heart-lung machines). The second is neuromodulation (implants for the treatment of epilepsy and depression). This chart shows analysts' growth estimates for these two specialized medical segments. It reflects the gap between the target price and the current price.
Analyst consensus forecast for stock prices by market segment - Miscellaneous medical equipment
LivaNova is a medical technology company focused on two distinct areas: cardiac surgery equipment and, more importantly, neuromodulation (devices for epilepsy treatment). This chart shows analysts' overall expectations for the entire MedTech sector. It reflects whether experts believe demand for these complex devices will grow.
Analysts' consensus forecast for the overall market share price
LivaNova (LIVN) is a company specializing in medical technologies for the treatment of cardiac and neurological diseases. They produce heart-lung machines and vagus nerve stimulators (VNS) for the treatment of epilepsy. This chart shows the overall market sentiment, reflecting analysts' confidence in the stability of high-tech healthcare spending.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index LivaNova PLC
LivaNova is a company that produces high-tech medical equipment focused on two areas: cardiac surgery (heart-lung machines) and neuromodulation (epilepsy treatment). This chart is a summary indicator of their niches. It likely reflects the volume of elective cardiac surgeries and the growing adoption of their devices for the treatment of neurological disorders.
AKIMA Market Segment Index - Miscellaneous medical equipment
LivaNova is a global medtech player focused on two niches: heart (cardiac surgery โ heart-lung machines) and brain (neuromodulation โ epilepsy treatment). This composite metric evaluates companies. The graph shows the average value for the sector. This benchmark: how does LivaNova's dual (heart + brain) niche strategy differentiate it from the average competitor?
The AKIM Index for the overall market
LivaNova is a MedTech company focused on critical care: neurology (stimulators for epilepsy) and cardiac surgery (heart-lung machines). This chart, reflecting the market average, is a backdrop. It helps assess how LivaNova, a defense business, fares against the backdrop of overall macroeconomic fluctuations.